Why Hepatitis E Can Become Deadly During Pregnancy
Quick Facts
Why Is Hepatitis E More Dangerous During Pregnancy?
Hepatitis E is a liver infection caused by the hepatitis E virus, or HEV. The World Health Organization estimates that approximately 20 million HEV infections occur worldwide each year, including about 3.3 million symptomatic cases. Most infections resolve without specific treatment, but pregnant patients—particularly during the second and third trimesters—face a substantially greater risk of acute liver failure, fetal loss and death.
The disparity is especially pronounced with HEV genotype 1, which is commonly transmitted through contaminated drinking water in areas with inadequate sanitation. WHO reports that fatality among infected women in the third trimester can reach 20% to 25% in some outbreaks. The risk is not uniform across every patient or viral genotype, but pregnancy is recognized as an important warning sign requiring prompt medical assessment.
How Could Pregnancy Biology Worsen Hepatitis E?
Researchers investigating the unusually severe outcomes have focused on more than generalized immune suppression. The newly reported work indicates that normal hormonal conditions associated with pregnancy may alter interactions among HEV, liver cells and antiviral defenses. This offers a biological explanation for why severe disease can emerge even when pregnancy itself is otherwise progressing normally.
Hormones, immune signaling, viral genotype, nutrition and underlying liver health may all contribute to the final outcome. A mechanistic finding therefore does not mean that hormones alone determine whether an infection becomes fatal. Further laboratory and clinical validation will be needed before the pathway can support a targeted treatment, risk test or preventive intervention.
How Can Hepatitis E Be Prevented and Managed During Pregnancy?
In regions where HEV spreads through contaminated water, prevention depends on safe drinking water, effective sewage disposal and hand hygiene. In places where foodborne transmission is more common, public-health agencies advise thoroughly cooking pork, wild game and shellfish and avoiding raw or undercooked animal products. A hepatitis E vaccine is licensed in China, but vaccination is not routinely available worldwide.
Pregnant people should seek urgent medical assessment for jaundice, dark urine, pale stools, persistent vomiting, marked fatigue or pain in the upper-right abdomen, particularly after possible exposure. Treatment for uncomplicated acute hepatitis E is generally supportive, while severe disease requires hospital monitoring and specialist care. Ribavirin, sometimes used for chronic HEV in selected nonpregnant patients, can harm a developing fetus and is contraindicated during pregnancy.
Frequently Asked Questions
Yes. Maternal hepatitis E can be associated with miscarriage, stillbirth, premature delivery and transmission of the virus to the baby, particularly when maternal illness is severe.
Routine screening is not generally recommended everywhere. Clinicians may order HEV antibody or molecular testing when a pregnant patient has acute hepatitis symptoms, abnormal liver tests or a relevant travel, food or water exposure.
No. Severity varies by viral genotype, stage of pregnancy and individual health factors, but pregnancy—especially the third trimester—warrants closer monitoring because the consequences can be serious.
References
- World Health Organization. Hepatitis E fact sheet.
- Centers for Disease Control and Prevention. Hepatitis E.
- Medical Xpress. How pregnancy itself drives deadly hepatitis E outcomes. August 2026.